| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenue: | ||||||
Total revenue | ||||||
1,022 | 2,757 | 860 | ||||
Operating expenses: | ||||||
Research and development | ||||||
24,083 | 23,000 | 17,438 | ||||
General and administrative | ||||||
6,026 | 3,874 | 3,160 | ||||
Total operating expenses | ||||||
30,109 | 26,874 | 20,598 | ||||
Loss from operations | ||||||
-29,087 | -24,117 | -19,738 | ||||
Other income (expense): | ||||||
Interest and other income, net | ||||||
357 | 420 | 234 | ||||
Change in fair value of warrant liability | ||||||
- | -1,632 | 5,152 | ||||
Share of loss from equity method investment | ||||||
-951 | -40 | - | ||||
Net loss | ||||||
-29,681 | -22,105 | -24,656 | ||||
Preferred dividends | ||||||
- | 1,357 | 2,793 | ||||
Net loss available to common stockholders | ||||||
-29,681 | -23,462 | -27,449 | ||||
Weighted-average common shares outstanding used in computing net loss per share available to common stockholders | ||||||
Weighted-average common shares outstanding used in computing net loss, basic and diluted | ||||||
8,458 | 3,146 | - | ||||
Basic (in shares) | ||||||
- | - | 166 | ||||
Diluted (in shares) | ||||||
- | - | 166 | ||||
Basic (in dollars per share) | ||||||
- | - | -148.20 | ||||
Diluted (in dollars per share) | ||||||
- | - | -148.20 | ||||
Preferred dividends: | ||||||
Basic (in dollars per share) | ||||||
- | - | 16.78 | ||||
Diluted (in dollars per share) | ||||||
- | - | 16.78 | ||||
Net loss per share available to common stockholders: | ||||||
Net loss per share, basic and diluted | ||||||
-3.51 | -7.45 | - | ||||
Basic (in dollars per share) | ||||||
- | - | -164.98 | ||||
Diluted (in dollars per share) | ||||||
- | - | -164.98 | ||||
Collaboration revenue | ||||||
Total revenue | ||||||
- | 1,168 | 771 | ||||
Research and development | ||||||
- | 604 | 633 | ||||
Grant revenue | ||||||
Total revenue | ||||||
1,022 | 1,589 | 89 | ||||